Total Payments
$7,992
2024 Payments
$1,503
Companies
25
Transactions
212
Medicare Patients
131
Medicare Billing
$11,738
Payment Breakdown by Category
Food & Beverage$7,931 (99.2%)
Education$60.99 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,931 | 210 | 99.2% |
| Education | $60.99 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,560 | 31 | $0 (2024) |
| ITI, Inc. | $828.79 | 22 | $0 (2023) |
| Alkermes, Inc. | $825.80 | 25 | $0 (2024) |
| ABBVIE INC. | $818.10 | 17 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $781.24 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $664.35 | 11 | $0 (2023) |
| Axsome Therapeutics, Inc. | $513.26 | 11 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $422.51 | 16 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $241.81 | 8 | $0 (2023) |
| Lundbeck LLC | $194.58 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,503 | 29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($781.24) |
| 2023 | $4,330 | 127 | Teva Pharmaceuticals USA, Inc. ($793.91) |
| 2022 | $2,041 | 55 | Teva Pharmaceuticals USA, Inc. ($516.60) |
| 2021 | $118.53 | 1 | Neurelis, Inc. ($118.53) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $118.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Opioid Use Disorder | ||||||
| 10/16/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $114.27 | General |
| Category: CNS | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $121.03 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.74 | General |
| Category: PSYCHIATRY | ||||||
| 06/30/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: OUD | ||||||
| 06/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: PSYCHIATRY | ||||||
| 06/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: PSYCHIATRY | ||||||
| 06/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: PSYCHIATRY | ||||||
| 05/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: PSYCHIATRY | ||||||
| 05/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 05/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: PSYCHIATRY | ||||||
| 05/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: PSYCHIATRY | ||||||
| 04/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neurology | ||||||
| 04/11/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: HCV | ||||||
| 04/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: PSYCHIATRY | ||||||
| 03/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 131 | 231 | $26,252 | $11,738 |
Total Patients
131
Total Services
231
Medicare Billing
$11,738
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 97 | $14,550 | $7,032 | 48.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 46 | 88 | $7,920 | $3,836 | 48.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 12 | $3,000 | $567.30 | 18.9% |
| 90785 | Psychiatric services complicated by communication factor | Office | 2023 | 22 | 34 | $782.00 | $302.87 | 38.7% |
About Richard Zawislak, NP
Richard Zawislak, NP is a Registered Nurse healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1265807440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Zawislak, NP has received a total of $7,992 in payments from pharmaceutical and medical device companies, with $1,503 received in 2024. These payments were reported across 212 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($7,931).
As a Medicare-enrolled provider, Zawislak has provided services to 131 Medicare beneficiaries, totaling 231 services with total Medicare billing of $11,738. Data is available for 1 year (2023–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location Buffalo, NY
- Active Since 12/14/2015
- Last Updated 11/29/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1265807440
Products in Payments
- CAPLYTA (Drug) $1,610
- AUSTEDO (Drug) $853.67
- VRAYLAR (Drug) $693.11
- SPRAVATO (Drug) $664.35
- UZEDY (Drug) $586.31
- ARISTADA (Drug) $548.33
- Auvelity (Drug) $500.59
- REXULTI (Drug) $426.61
- LYBALVI (Drug) $227.96
- INGREZZA (Drug) $169.34
- BOTOX (Biological) $124.99
- Austedo XR (Drug) $120.51
- VALTOCO (Drug) $118.53
- TRINTELLIX (Drug) $118.41
- COBENFY (Drug) $118.27
- HETLIOZ (Drug) $103.15
- ABILIFY MAINTENA (Drug) $90.82
- NUEDEXTA (Drug) $60.82
- Azstarys (Drug) $50.64
- APLENZIN (Drug) $46.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Buffalo
Linda Fuller, Anp, Cde, ANP, CDE
Registered Nurse — Payments: $5,637
Registered Nurse $5,637
Ms. Kelly Mclean, Fnp-C, FNP-C
Registered Nurse — Payments: $4,278
Registered Nurse $4,278
Amanda Block
Registered Nurse — Payments: $4,217
Registered Nurse $4,217
Zoe Spyralatos
Registered Nurse — Payments: $3,784
Registered Nurse $3,784
Seolar Jackson, Pmnp-Bc, PMNP-BC
Registered Nurse — Payments: $3,020
Registered Nurse $3,020
Claire Yaple
Registered Nurse — Payments: $2,909
Registered Nurse $2,909